Ashley Gunzelman
Family · China Grove, NCNPI 1730545401
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 288 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,989 and has fallen 96.9% since, to $123 in 2024. Among family clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $23.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Paratek Pharmaceuticals, Inc.$845
- AstraZeneca$567
- Johnson & Johnson$404
- Biohaven Pharmaceuticals, Inc.$349
- Pfizer$282
- plus $3K from 29 others
What the payments were for
- Food & beverage$6,75699%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $1,042 |
| Paratek Pharmaceuticals, Inc. | 20 | $845 |
| AstraZeneca | 14 | $567 |
| Johnson & Johnson | 10 | $404 |
| Biohaven Pharmaceuticals, Inc. | 13 | $349 |
| Pfizer | 17 | $282 |
| Argenx US, Inc. | 3 | $257 |
| Bayer | 14 | $237 |
| Gilead | 2 | $220 |
| Sanofi-aventis U.S. LLC | 9 | $220 |
| Astellas Pharma US Inc | 7 | $215 |
| Kowa Pharmaceuticals America, Inc. | 15 | $209 |
| Novo Nordisk | 6 | $186 |
| GSK | 13 | $180 |
| Lilly USA, LLC | 13 | $177 |
| Amgen | 12 | $150 |
| Boehringer Ingelheim | 8 | $137 |
| Amarin Pharma, Inc. | 16 | $130 |
| Idorsia Pharmaceuticals US Inc | 1 | $130 |
| Clarus Therapeutics Inc. | 8 | $128 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $107 |
| Eisai Inc. | 7 | $93 |
| Ultragenyx Pharmaceutical Inc. | 1 | $89 |
| Currax Pharmaceuticals LLC | 5 | $68 |
| Merck | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $53 |
| Hikma Pharmaceuticals USA | 4 | $50 |
| Acerus Pharmaceuticals Corporation | 3 | $41 |
| Ironwood Pharmaceuticals, Inc | 2 | $31 |
| Antares Pharma, Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,856 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Other family in China Grove
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.